{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:57:10Z","timestamp":1790351830912,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/eye.2015.40","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T10:56:35Z","timestamp":1428663395000},"page":"808-814","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications"],"prefix":"10.1038","volume":"29","author":[{"given":"M","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Dada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Vanathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"issue":"7","key":"BFeye201540_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0161-6420(92)31847-0","volume":"99","author":"JM Herreras","year":"1992","unstructured":"Herreras JM, Pastor JC, Calonge M, Asensio VM . Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology 1992; 99 (7): 1082\u20131088.","journal-title":"Ophthalmology"},{"issue":"9","key":"BFeye201540_CR2","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1167\/iovs.04-0251","volume":"45","author":"JM Ben\u0131\u2019tez del Castillo","year":"2004","unstructured":"Ben\u0131\u2019tez del Castillo JM, Wasfy MA, Fernandez C, Garcia-Sanchez J . An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci 2004; 45 (9): 3030\u20133035.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"BFeye201540_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1006\/exer.1994.1145","volume":"59","author":"J Garcia-Hirschfeld","year":"1994","unstructured":"Garcia-Hirschfeld J, Lopez-Briones L, Belmonte C . Neurotrophic influences on corneal epithelial cells. Exp Eye Res 1994; 59 (5): 597\u2013605.","journal-title":"Exp Eye Res"},{"issue":"1","key":"BFeye201540_CR4","first-page":"137","volume":"34","author":"KS Baker","year":"1993","unstructured":"Baker KS, Anderson SC, Romanowski EG, Thoft RA, SundarRaj N . Trigeminal ganglion neurons affect corneal epithelial phenotype: influence on type VII collagen expression in vitro. Invest Ophthalmol Vis Sci 1993; 34 (1): 137\u2013144.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"BFeye201540_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ajo.2008.10.019","volume":"147","author":"G Martone","year":"2009","unstructured":"Martone G, Frezzotti P, Tosi GM, Traversi C, Mittica V, Malandrini A et al. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol 2009; 147 (4): 725\u2013735.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"BFeye201540_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1167\/iovs.06-0127","volume":"48","author":"JM Ben\u00edtez-Del-Castillo","year":"2007","unstructured":"Ben\u00edtez-Del-Castillo JM, Acosta MC, Wassfi MA, D\u00edaz-Valle D, Geg\u00fandez JA, Fernandez C et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci 2007; 48 (1): 173\u2013181.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"BFeye201540_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00417-014-2618-2","volume":"252","author":"Y Qazi","year":"2014","unstructured":"Qazi Y, Aggarwal S, Hamrah P . Image-guided evaluation and monitoring of treatment response in patients with dry eye disease. Graefes Arch Clin Exp Ophthalmol 2014; 252 (6): 857\u2013872.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"BFeye201540_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/02713683.2013.842592","volume":"39","author":"E Villani","year":"2014","unstructured":"Villani E, Baudouin C, Efron M, Hamrah P, Kojima T, Patel SV et al. In vivo confocal microscopy of the ocular surface: from bench to bedside. Curr Eye Res 2014; 39 (3): 213\u2013231.","journal-title":"Curr Eye Res"},{"issue":"5","key":"BFeye201540_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/ACI.0b013e328364ec92","volume":"13","author":"E Villani","year":"2013","unstructured":"Villani E, Mantelli F, Nucci P . In-vivo confocal microscopy of the ocular surface: ocular allergy and dry eye. Curr Opin Allergy Clin Immunol 2013; 13 (5): 569\u2013576.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"BFeye201540_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/OPX.0b013e318294c184","volume":"90","author":"E Villani","year":"2013","unstructured":"Villani E, Magnani F, Viola F, Santaniello A, Scorza R, Nucci P et al. In vivo confocal evaluation of the ocular surface morpho-functional unit in dry eye. Optom Vis Sci 2013; 90 (6): 576\u2013586.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"BFeye201540_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1017\/S1431927614000324","volume":"20","author":"L Mastropasqua","year":"2014","unstructured":"Mastropasqua L, Agnifili L, Mastropasqua R, Fasanella V, Nubile M, Toto L et al. In vivo laser scanning confocal microscopy of the ocular surface in glaucoma. Microsc Microanal 2014; 20 (3): 879\u2013894.","journal-title":"Microsc Microanal"},{"issue":"5","key":"BFeye201540_CR12","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1111\/aos.12131","volume":"91","author":"L Mastropasqua","year":"2013","unstructured":"Mastropasqua L, Agnifili L, Fasanella V, Curcio C, Ciabattoni C, Mastropasqua R et al. Conjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: an in vivo confocal microscopy and impression cytology study. Acta Ophthalmol 2013; 91 (5): e397\u2013e405.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"BFeye201540_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/bjophthalmol-2012-302597","volume":"97","author":"L Agnifili","year":"2013","unstructured":"Agnifili L, Fasanella V, Costagliola C, Ciabattoni C, Mastropasqua R, Frezzotti P et al. In vivo confocal microscopy of meibomian glands in glaucoma. Br J Ophthalmol 2013; 97 (3): 343\u2013349.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"BFeye201540_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/01.ico.0000230499.07273.c5","volume":"25","author":"KH Baratz","year":"2006","unstructured":"Baratz KH, Nau CB, Winter EJ, McLaren JW, Hodge DO, Herman DC et al. Effects of glaucoma medications on corneal endothelium, keratocytes, and subbasal nerves among participants in the ocular hypertension treatment study. Cornea 2006; 25 (9): 1046\u20131052.","journal-title":"Cornea"},{"issue":"7","key":"BFeye201540_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1097\/ICO.0000000000000123","volume":"33","author":"XQ Zhou","year":"2014","unstructured":"Zhou XQ, Wei RL . Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis. Cornea 2014; 33 (7): 760\u2013767.","journal-title":"Cornea"},{"key":"BFeye201540_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000334248","volume":"48","author":"HK Cho","year":"2012","unstructured":"Cho HK, Park MH, Moon JI . The effect of additional topical cyclosporin or vitamin A on the ocular surface during antiglaucoma medication administration. Ophthalmic Res 2012; 48: 139\u2013145.","journal-title":"Ophthalmic Res"},{"key":"BFeye201540_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","volume":"153","author":"SE Skalicky","year":"2012","unstructured":"Skalicky SE, Goldberg I, McCluskey P . Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol 2012; 153: 1\u20139.","journal-title":"Am J Ophthalmol"},{"key":"BFeye201540_CR18","first-page":"39","volume-title":"Dry Eye Disease: The Clinician's Guide to Diagnosis and Treatment","author":"JD Nelson","year":"2006","unstructured":"Nelson JD . In office diagnostic tests for dry eye disease. In: Asbell PA, Lemp MA (eds). Dry Eye Disease: The Clinician's Guide to Diagnosis and Treatment. Thieme Medical Publishers, Inc.: New York, NY, USA, 2006 pp 39\u201344."},{"key":"BFeye201540_CR19","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","volume":"25","author":"A Behrens","year":"2006","unstructured":"Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT et al Dysfunctional tear syndrome study group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006; 25: 900\u2013907.","journal-title":"Cornea"},{"key":"BFeye201540_CR20","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007; 5: 75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"BFeye201540_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","volume":"17","author":"EW Leung","year":"2008","unstructured":"Leung EW, Medeiros FA, Weinreb RN . Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008; 17: 350\u2013355.","journal-title":"J Glaucoma"},{"issue":"4","key":"BFeye201540_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"PJ Pisella","year":"2002","unstructured":"Pisella PJ, Pouliquen P, Baudouin C . Prevalence of ocularsymptoms and signs with preserved and preservative-free glaucoma medication. Br J Ophthalmol 2002; 86 (4): 418\u2013423.","journal-title":"Br J Ophthalmol"},{"key":"BFeye201540_CR23","first-page":"696328","volume":"2013","author":"S Ka\u0161telan","year":"2013","unstructured":"Ka\u0161telan S, Tomi\u0107 M, Mete\u017e Soldo K, Salopek-Rabati\u0107 J . How ocular surface disease impacts the glaucoma treatment outcome. Biomed Res Int 2013; 2013: 696328.","journal-title":"Biomed Res Int"},{"issue":"4","key":"BFeye201540_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12325-013-0021-8","volume":"30","author":"S Lee","year":"2013","unstructured":"Lee S, Kim MK, Choi HJ, Wee WR, Kim DM . Comparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surface. Adv Ther 2013; 30 (4): 420\u2013429.","journal-title":"Adv Ther"},{"key":"BFeye201540_CR25","first-page":"2131","volume":"7","author":"LM Rosin","year":"2013","unstructured":"Rosin LM, Bell NP . Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops. Clin Ophthalmol 2013; 7: 2131\u20132135.","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"BFeye201540_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1089\/jop.2013.0216","volume":"30","author":"M Iester","year":"2014","unstructured":"Iester M, Telani S, Frezzotti P, Motolese I, Figus M, Fogagnolo P et al. Ocular Surface changes in glaucomatous patients treated with and without preservatives beta-blockers. J Ocul Pharmacol Ther 2014; 30 (6): 476\u2013481.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"BFeye201540_CR27","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.6061\/clinics\/2013(10)05","volume":"68","author":"HH Russ","year":"2013","unstructured":"Russ HH, Nogueira-Filho PA, Barros Jde N, de Faria NV, Montiani-Ferreira F, Gomes J\u00c1 et al. Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial. Clinics (Sao Paulo) 2013; 68 (10): 1318\u20131324.","journal-title":"Clinics (Sao Paulo)"},{"key":"BFeye201540_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1442-9071.2000.00237.x","volume":"28","author":"MK Arici","year":"2000","unstructured":"Arici MK, Arici DS, Topalkara A, Guler C . Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Experiment Ophthalmol 2000; 28: 113\u2013117.","journal-title":"Clin Experiment Ophthalmol"},{"key":"BFeye201540_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0014-4835(03)00050-2","volume":"76","author":"LJ Muller","year":"2003","unstructured":"Muller LJ, Marfurt CF, Kruse F, Tervo TM . Corneal nerves: structures, contents and function. Exp Eye Res 2003; 76: 521\u2013542.","journal-title":"Exp Eye Res"},{"key":"BFeye201540_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"K Sall","year":"2000","unstructured":"Sall K, Stevenson OD, Mundorf TK, Reis BL . Two multicenter,randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000; 107: 631\u2013639.","journal-title":"Ophthalmology"},{"issue":"4","key":"BFeye201540_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/OPTH.S1409","volume":"2","author":"GD Kymionis","year":"2008","unstructured":"Kymionis GD, Bouzoukis DI, Diakonis VF, Siganos C . Treatment of chronic dry eye: focus on cyclosporine. Clin Ophthalmol 2008; 2 (4): 829\u2013836.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"BFeye201540_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archopht.120.3.330","volume":"120","author":"KS Kunert","year":"2002","unstructured":"Kunert KS, Tisdale AS, Gipson IK . Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 2002; 120 (3): 330\u2013337.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"BFeye201540_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","volume":"27","author":"SC Pflugfelder","year":"2008","unstructured":"Pflugfelder SC, De Paiva CS, Villarreal AL, Stern ME . Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea 2008; 27 (1): 64\u201369.","journal-title":"Cornea"},{"issue":"11","key":"BFeye201540_CR34","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.ophtha.2013.03.045","volume":"120","author":"PM Mathews","year":"2013","unstructured":"Mathews PM, Ramulu PY, Friedman DS, Utine CA, Akpek EK . Evaluation of ocular surface disease in patients with glaucoma. Ophthalmology 2013; 120 (11): 2241\u20132248.","journal-title":"Ophthalmology"},{"key":"BFeye201540_CR35","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/ICO.0b013e318193e0e3","volume":"28","author":"DV Patel","year":"2009","unstructured":"Patel DV, Tavakoli M, Craig JP, Efron N, McGhee CNJ . Corneal Sensitivity and Slit Scanning In Vivo Confocal Microscopy of the Subbasal Nerve Plexus of the Normal Central and Peripheral Human Cornea. Cornea 2009; 28: 735\u2013740.","journal-title":"Cornea"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye201540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201540","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:26:44Z","timestamp":1684430804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye201540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFeye201540"],"URL":"https:\/\/doi.org\/10.1038\/eye.2015.40","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,10]]},"assertion":[{"value":"3 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}